VAG
GMED icon

VisionPoint Advisory Group’s Globus Medical GMED Stock Holding History

VisionPoint Advisory Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4
Closed -$215 – 842
2024
Q1 		$215 Buy
+4
New +$215 ﹤0.01% 764

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VisionPoint Advisory Group's GMED Position: Q2 2024 in Review

VisionPoint Advisory Group sold out of Globus Medical (GMED) in Q2 2024, closing a stake of 4 shares — an estimated $215 sold.

VisionPoint Advisory Group first reported a position in GMED in Q1 2024 and held it in 1 quarter. The position peaked at $215 in Q1 2024. 450 funds tracked by Wall St. Rank hold GMED as of Q2 2024.

  • VisionPoint Advisory Group reported no remaining Globus Medical position as of Q2 2024 after selling out during the quarter.
  • VisionPoint Advisory Group sold 4 Globus Medical shares in Q2 2024, an estimated $215.
  • VisionPoint Advisory Group first reported a position in Globus Medical in Q1 2024 and held it in 1 quarter.
  • VisionPoint Advisory Group's Globus Medical position peaked at $215 in Q1 2024.
  • 450 funds tracked by Wall St. Rank held Globus Medical as of Q2 2024.

Based on VisionPoint Advisory Group's 13F filing for Q2 2024, filed 1 Aug 2024.